Tag Archives: Events

BIO Housing Inventory Going Fast

Chicago

With roughly 80,000 bioscience jobs in more than 3,500 businesses across all bioscience sectors, it is no wonder the 2013 BIO International Convention is returning to Chicago, April 22- 25, 2013. With a large presence in all biotech sectors – agricultural feedstock and chemicals, drugs and pharma, medical devices and equipment, research, testing and medical laboratories and bioscience-related distribution, attendees will have the opportunity to meet with and visit premier R&D facilities, from national laboratories Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

20th Anniversary of the BIO International Convention

Jim Greenwood

Next year BIO will celebrate the 20th anniversary of the BIO International Convention April 22-25 in Chicago. From a small beginning, our convention has grown into the most influential biotech meeting in the world, attracting more than 16,500 attendees from 65 countries and providing a wide array of education, exhibits and networking opportunities — including more than 25,000 partnering meetings expected during the 4-day event. As we look forward to the upcoming Convention, I cannot Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

eAdvocacy Summit Brings Together More Than 130 Groups

eAdvocacy-Summit-btn

BIO’s mission is to champion biotechnology issues by advocating for policies that will enable the realization of breakthrough products to cure disease, feed the hungry, and clean our environment. Fortunately, we are not alone – our many alliance and advocacy partners share our goal. When smart, like-minded people get together, good things tend to happen. That’s why I’m looking forward to tomorrow’s eAdvocacy Summit here in Washington, DC. The Global Healthy Living Foundation (GHLF) and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

BIO Investor Forum – Raring to Go: The Race to Treat Ultra-Rare Diseases

BIO Investor Forum

The signing of FDASIA by President Obama in July reinforces the country’s commitment to fostering innovation for rare diseases. With a record 460 medicines in late-stage clinical trials, biopharmaceutical companies have embraced rare disease medicine and are rapidly developing the pipeline. In anticipation of an even more compelling opportunity, many companies are taking a step beyond and focusing on ultra rare diseases. Last week’s 11th Annual BIO Investor Forum in San Francisco hosted a panel, Raring Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable

bio-india-btn

During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,